Gerald M. Lieberman - 01 Apr 2025 Form 4 Insider Report for Entera Bio Ltd. (ENTX)

Role
Director
Signature
/s/ Dana Yaacov-Garbeli, Attorney-in-Fact
Issuer symbol
ENTX
Transactions as of
01 Apr 2025
Net transactions value
+$23,952
Form type
4
Filing time
03 Apr 2025, 16:06:27 UTC
Previous filing
17 Jan 2025
Next filing
09 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENTX Ordinary Shares, par value NIS 0.0000769 per share Options Exercise $23,952 +23,952 +8.7% $1.00 300,160 01 Apr 2025 Direct
holding ENTX Ordinary Shares, par value NIS 0.0000769 per share 6,200 01 Apr 2025 By Trust F1
holding ENTX Ordinary Shares, par value NIS 0.0000769 per share 6,200 01 Apr 2025 By Trust F1
holding ENTX Ordinary Shares, par value NIS 0.0000769 per share 6,200 01 Apr 2025 By Trust F1
holding ENTX Ordinary Shares, par value NIS 0.0000769 per share 6,200 01 Apr 2025 By Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENTX Warrant (right to buy) Options Exercise $0 -23,952 -46% $0.000000 28,509 01 Apr 2025 Ordinary Shares, par value NIS 0.0000769 per share 23,952 $1.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are owned by a Trust of which the Reporting Person's grandchild is the beneficiary, and the Reporting Person's spouse is the Trustee. The Reporting Person disclaims beneficial ownership of the securities held by this trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.